Collegium Pharmaceutical, Inc.COLLNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$341.70M
↑ 272% above average
Average (9y)
$91.91M
Historical baseline
Range
High:$341.70M
Low:$-93.43M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $341.70M | +10.8% |
| 2023 | $308.33M | +77.9% |
| 2022 | $173.31M | +100.2% |
| 2021 | $86.56M | -26.7% |
| 2020 | $118.01M | +1964.4% |
| 2019 | $-6.33M | -106.9% |
| 2018 | $91.91M | +223.7% |
| 2017 | $-74.27M | +20.5% |
| 2016 | $-93.43M | -250.6% |
| 2015 | $-26.64M | - |